(Q28199107)

English

Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib

scientific article (publication date: 15 August 2003)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib (English)

0 references

1 reference

William B White

1

0 references

Gerald Faich

series ordinal

2

0 references

Jeffrey S Borer

series ordinal

3

0 references

Robert W Makuch

series ordinal

4

0 references

language of work or name

English

0 references

publication date

15 August 2003

0 references

published in

American Journal of Cardiology

0 references

volume

92

0 references

issue

4

0 references

page(s)

411-8

0 references

cites work

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900659-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900659-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900659-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of prostacyclin in the cardiovascular response to thromboxane A2

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900659-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900659-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900659-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900659-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900659-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900659-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900659-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900659-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900659-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900659-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Atherosclerosis — An Inflammatory Disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900659-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900659-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0002-9149(03)00659-3

0 references

PubMed ID

12914871

0 references

(Q28199107)

Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)